| Heading: |
Alzheimer's Disease: Health Services |
| Question ID: |
1804770 |
| UIN: |
HL7717 |
| House: |
Lords |
| Date tabled: |
2025-05-20 |
| Asking Member ID: |
4970 |
| Asking Member display name: |
Lord Weir of Ballyholme
|
| Asking Member handle: |
LordWeirDUP
|
| Asking Member Twitter reference: |
@LordWeirDUP
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what steps they are taking to prioritise timely referral, accurate biomarker-led diagnoses and access to post diagnostic support and treatment for Alzheimer's disease. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
We recognise the importance of a timely diagnosis and remain committed to increasing diagnosis rates and ensuring that people can access any licensed and National Institute for Health and Care Excellence recommended treatment, as well as any support, they... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |